2022
Commentary: Psychiatric Symptoms Related to Somatic Illness
Garakani A. Commentary: Psychiatric Symptoms Related to Somatic Illness. Journal Of Psychiatric Practice 2022, 28: 514-515. PMID: 36355593, DOI: 10.1097/pra.0000000000000674.Commentaries, Editorials and LettersConceptsAuditory hallucinationsVisual hallucinationsPsychiatric historySomatic illnessPatient's psychiatric historySemicircular canal dehiscencePsychosis presentPsychiatric consultation serviceCharles Bonnet syndromeCanal dehiscenceHypertensive episodesCases of hallucinationsPsychiatric symptomsPsychotic symptomsPsychotic disordersProper diagnosisMedical providersPatientsMedical teamSymptomsConsultation serviceHallucinationsThought disorderIllnessDisorders
2021
Commentary: Diagnostic and Treatment Issues in Psychosis
Garakani A. Commentary: Diagnostic and Treatment Issues in Psychosis. Journal Of Psychiatric Practice 2021, 27: 338-339. PMID: 34398586, DOI: 10.1097/pra.0000000000000562.Commentaries, Editorials and LettersMeSH KeywordsAntipsychotic AgentsFemaleHumansPsychotic DisordersSchizophreniaSelf-Injurious BehaviorViolenceConceptsPsychotic symptomsUse of intranasalWide differential diagnosisFirst-episode schizophreniaMore common conditionsRare presentationPostpartum periodDifferential diagnosisPsychotic episodeCommon conditionSymptomsTreatment issuesPeriodic catatoniaPatientsFirst caseThird caseDiagnosisTreatmentBroad spectrumCommentary: Diagnostic Challenges in Evaluating Adolescents
Garakani A. Commentary: Diagnostic Challenges in Evaluating Adolescents. Journal Of Psychiatric Practice 2021, 27: 239-240. PMID: 33939380, DOI: 10.1097/pra.0000000000000553.Commentaries, Editorials and LettersMeSH KeywordsAdolescentAdultAntipsychotic AgentsDelusionsFemaleHallucinationsHumansPsychotic DisordersSchizophreniaConceptsDiagnostic challengeConstellation of symptomsProminent mood symptomsPosttraumatic stress disorderFemale patientsTrauma-related symptomsMedication treatmentAntipsychotic medicationAdolescent patientsUnnecessary treatmentVisual hallucinationsDifferential diagnosisPatient reportsTerms of stigmaMood symptomsDepressive symptomsPsychotic symptomsSide effectsPatientsPsychotic disordersSuicidal ideasFull differential diagnosisAuditory hallucinationsCotard's syndromeIncorrect diagnosis
2020
The effects of augmenting clozapine with oxytocin in schizophrenia: An initial case series.
Marotta RF, Buono FD, Garakani A, Collins E, Cerrito B, David Rowe DR. The effects of augmenting clozapine with oxytocin in schizophrenia: An initial case series. Annals Of Clinical Psychiatry 2020, 32: 90-96. PMID: 32343282.Peer-Reviewed Case Reports and Technical NotesConceptsTreatment-resistant schizophreniaNegative symptomsAtypical antipsychoticsRetrospective chart reviewInitial case seriesAugmentation of clozapineChronic psychotic illnessNegative Syndrome ScaleYoung adult inpatientsSymptoms of schizophreniaParent/guardian reportsChart reviewCase seriesAdult inpatientsProspective studyAntipsychotic medicationClinical reviewTherapeutic responsePsychotic illnessTreatment approachesSyndrome ScalePositive symptomsTreating psychiatristSymptomsSustained treatment
2013
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse
Leibu E, Garakani A, McGonigle DP, Liebman LS, Loh D, Bryson EO, Kellner CH. Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse. Journal Of Ect 2013, 29: e61-e62. PMID: 23670023, DOI: 10.1097/yct.0b013e318290fa36.Peer-Reviewed Case Reports and Technical NotesMeSH KeywordsAdultCannabisCatatoniaDesigner DrugsElectroconvulsive TherapyHumansMaleMarijuana AbuseSchizophreniaTreatment Outcome
2010
Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
Krystal JH, Mathew SJ, D’Souza D, Garakani A, Gunduz-Bruce H, Charney DS. Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists. CNS Drugs 2010, 24: 669-693. PMID: 20658799, DOI: 10.2165/11533230-000000000-00000.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPreliminary clinical trialsPositive allosteric modulatorsPsychiatric disordersClinical trialsAnimal modelsAllosteric modulatorsGroup II mGluR agonistGroup IMetabotropic glutamate receptor agonistAnxiety disordersPotential psychiatric applicationsGlutamate receptor agonistsMetabotropic glutamate receptorsTreatment of schizophreniaRole of glutamateForm of depressionMGluR agonistAntidepressant propertiesMGluR5 agonistReceptor agonistGlutamate receptorsMood disordersArea of schizophreniaPromising agentAgonists
2003
Electrolyte-Balanced Sports Drink for Polydipsia-Hyponatremia in Schizophrenia
Quitkin FM, Garakani A, Kelly KE. Electrolyte-Balanced Sports Drink for Polydipsia-Hyponatremia in Schizophrenia. American Journal Of Psychiatry 2003, 160: 385-a-386. PMID: 12562594, DOI: 10.1176/appi.ajp.160.2.385-a.Peer-Reviewed Case Reports and Technical NotesComorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A Review
Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS. Comorbidity of Irritable Bowel Syndrome in Psychiatric Patients: A Review. American Journal Of Therapeutics 2003, 10: 61-67. PMID: 12522523, DOI: 10.1097/00045391-200301000-00014.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsColonic Diseases, FunctionalComorbidityDepressive DisorderHumansPrevalenceSchizophreniaUnited StatesConceptsIrritable bowel syndromePsychiatric patientsBowel syndromeChronic abdominal discomfortFunctional gastrointestinal disordersU.S. adult populationStool frequencyAbdominal bloatingAbdominal discomfortPresence of mucusGastrointestinal disordersPsychiatric comorbidityMajor depressionHigh prevalencePanic disorderPatientsAdult populationComorbiditiesAnxiety disordersSyndromeDisordersPrevalenceTreatmentRecent studiesBloating